Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer’s Disease and Dementia with Lewy Bodies-Reference-Cited by-同舟云学术

Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer’s Disease and Dementia with Lewy Bodies

Published:2016-04-12 Issue:4 Volume:51 Page:1069-1083
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Bousiges Olivier¹²,Cretin Benjamin³⁴⁵,Lavaux Thomas¹,Philippi Nathalie³⁴⁵⁶,Jung Barbara³⁴⁵⁶,Hezard Sylvie¹,Heitz Camille³⁴⁵,Demuynck Catherine³⁴⁵⁶,Gabel Aurelia¹,Martin-Hunyadi Catherine⁵⁶,Blanc Frédéric³⁴⁵⁶

Affiliation:

1. University Hospital of Strasbourg, Laboratory of Biochemistry and Molecular Biology, Strasbourg, France

2. University of Strasbourg and CNRS, Laboratoire de Neurosciences Cognitives et Adaptatives (LNCA), UMR7364, Strasbourg, France

3. University Hospital of Strasbourg, Neuropsychology Unit, Neurology Service, Strasbourg, France

4. University of Strasbourg and CNRS, ICube laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), team IMIS/Neurocrypto, Strasbourg, France

5. University Hospital of Strasbourg, CMRR (Memory Resources and Research Centre), Strasbourg, France

6. University Hospital of Strasbourg, Geriatrics Day Hospital, Geriatrics Service, Strasbourg, France

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference58 articles.

1. A systematic review of prevalence and incidence studies of dementia with Lewy bodies;Zaccai;Age Ageing,2005

2. Dementia with Lewy bodies;McKeith;Lancet Neurol,2004

3. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: A clinicopathological study;Molano;Brain,2010

4. Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease;Jicha;Neurobiol Aging,2010

5. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop;McKeith;Neurology,1996

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: an update of the literature;Expert Review of Neurotherapeutics;2024-09-04

2. Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians;Neurology and Therapy;2024-05-08

3. A critical appraisal of blood-based biomarkers for Alzheimer’s disease;Ageing Research Reviews;2024-04

4. Markers for the detection of Lewy body disease versus Alzheimer’s disease in mild cognitive impairment: a systematic review and meta-analysis;Aging Clinical and Experimental Research;2024-03-07

5. Diagnostic value of CSF chromogranin A to discriminate between Alzheimer's disease and dementia with Lewy bodies;Neuropathology and Applied Neurobiology;2024-02